BIOMAT Database Logo BIOMAT Database Logo

Atrial natriuretic peptide inhibits the aldosterone response to metoclopramide in patients with glomerular disease and essential hypertension. 1991

H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Second Department of Internal Medicine, University of Tokyo, Japan.

1. We examined the effects of metoclopramide (MCP: 10 mg i.v.) on plasma atrial natriuretic peptide (ANP) and aldosterone concentrations (PAC) and the effect of ANP on MCP-induced PAC in four patients with primary glomerular diseases and seven patients with essential hypertension. 2. MCP injection caused no significant changes in plasma ANP. MCP produced a marked increase in PAC without a significant change in plasma renin activity. 3. The increase in PAC induced by MCP injection was markedly attenuated when preceded by the infusion of ANP (25 ng/kg per min). 4. These results suggest that the dopaminergic D2 mechanism is not involved in the regulation of ANP secretion and that ANP modulates the dopaminergic regulation of aldosterone secretion.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man.
May 1986, Clinical science (London, England : 1979),
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide.
September 1990, Critical care medicine,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Untangling Essential Hypertension: The Potential Roles of Aldosterone and Atrial Natriuretic Peptide.
August 2018, Mayo Clinic proceedings,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.
July 1991, British journal of clinical pharmacology,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
April 1984, Journal of hypertension,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
January 1997, Cardiology,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Response of atrial natriuretic peptide to acute saline loading in essential hypertension.
December 1988, The American journal of physiology,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Atrial natriuretic peptide response to postural changes in patients with left atrial hypertension.
December 1990, European heart journal,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Atrial natriuretic peptide and aldosterone synthase gene in essential hypertension: a case-control study.
August 2015, Gene,
H Matsuoka, and K Fukui, and Y Dan, and T Ishimitsu, and Y Hirata, and K Kimura, and T Sugimoto, and M Ishii, and K Kangawa, and H Matsuo
Atrial natriuretic peptide in human essential hypertension.
September 1987, Mayo Clinic proceedings,
Copied contents to your clipboard!